Literature DB >> 1472112

Does sorbinil bind to the substrate binding site of aldose reductase?

S Q Liu1, A Bhatnagar, S K Srivastava.   

Abstract

With benzyl alcohol as the varied substrate, sorbinil was found to be a competitive inhibitor of aldose reductase, an enzyme implicated in the etiology of secondary diabetic complications. The K(is sorbinil) and the Vmax/Km (V/K) benzyl alcohol decreased at low pH with a pK of 7.5 and 7.7, respectively. These observations suggest that both sorbinil and benzyl alcohol bind to the same site on the enzyme. Active site inhibition by sorbinil is consistent with non-competitive inhibition patterns of sorbinil with nucleotide coenzyme or aldehyde as the varied substrate in the direction of aldehyde reduction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1472112     DOI: 10.1016/0006-2952(92)90693-d

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  4 in total

1.  B-factor Analysis and Conformational Rearrangement of Aldose Reductase.

Authors:  Ganesaratnam K Balendiran; J Rajendran Pandian; Evin Drake; Anubhav Vinayak; Malkhey Verma; Duilio Cascio
Journal:  Curr Proteomics       Date:  2014       Impact factor: 0.837

Review 2.  The aldo-keto reductase superfamily and its role in drug metabolism and detoxification.

Authors:  Oleg A Barski; Srinivas M Tipparaju; Aruni Bhatnagar
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

3.  The role of Cys-298 in aldose reductase function.

Authors:  Ganesaratnam K Balendiran; Michael R Sawaya; Frederick P Schwarz; Gomathinayagam Ponniah; Richard Cuckovich; Malkhey Verma; Duilio Cascio
Journal:  J Biol Chem       Date:  2010-11-17       Impact factor: 5.157

4.  Protective Pleiotropic Effect of Flavonoids on NAD⁺ Levels in Endothelial Cells Exposed to High Glucose.

Authors:  Daniëlle M P H J Boesten; Saskia N I von Ungern-Sternberg; Gertjan J M den Hartog; Aalt Bast
Journal:  Oxid Med Cell Longev       Date:  2015-06-09       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.